HER2-Positive

Novel CAR T-Cell Therapy Targets Aggressive HER2+ Breast Cancer

Novel CAR T-Cell Therapy Targets Aggressive HER2+ Breast Cancer

Yash Kiran Kamble

27 Nov 2024

4 min read

Lapatinib Increases Survival in Metastatic Breast Cancer Patients with HER2-Positive Tumor Cells

Lapatinib Increases Survival in Metastatic Breast Cancer Patients with HER2-Positive Tumor Cells

12 Jan 2024

3 min read

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

Trastuzumab Deruxtecan Improves Survival for Patients with HER2-Positive Metastatic Breast Cancer

13 May 2023

2 min read

Medbound Times

www.medboundtimes.com